• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders

    5/30/25 5:19:46 PM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email
    cg-20250529
    false000152716600015271662025-05-292025-05-290001527166us-gaap:CommonStockMember2025-05-292025-05-290001527166us-gaap:SubordinatedDebtMember2025-05-292025-05-29
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 29, 2025
    Carlyle-Logo-blue.jpg
    The Carlyle Group Inc.
    (Exact name of registrant as specified in its charter)
    Delaware
     
    001-35538
     
    45-2832612
    (State or Other Jurisdiction
    of Incorporation)
     
    (Commission
    File Number)
     
    (IRS Employer
    Identification No.)
    1001 Pennsylvania Avenue, NW
    Washington, DC 20004-2505
    (Address of Principal Executive Offices, Including Zip Code)
    (202) 729-5626
    (Registrant’s Telephone Number, Including Area Code)
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
    of the following provisions (see General Instruction A.2. below):
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common Stock
    CG
    The Nasdaq Global Select Market
    4.625% Subordinated Notes due 2061 of Carlyle Finance
    L.L.C.
    CGABL
    The Nasdaq Global Select Market
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
    of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
    with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
    Item 1.01
    Entry into a Material Definitive Agreement.
    The information required by this Item 1.01 is included in Item 2.03 and is incorporated herein by reference.
    Item 2.03
    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance
    Sheet Arrangement of a Registrant.
    On May 29, 2025, certain subsidiaries of The Carlyle Group Inc. (the “Company”) entered into a Third Amended and Restated
    Credit Agreement, which further amends and restates its existing Second Amended and Restated Credit Agreement, dated as of
    April 29, 2022, with the lenders thereto (listed below) and Citibank, N.A. as Administrative Agent. In connection with entering
    into the Third Amended and Restated Credit Agreement, the Company maintained the size of its revolving credit facility at $1.0
    billion. The Company currently has no amounts outstanding under the revolving credit facility. The Company has the ability to
    increase the size of its revolving credit facility (and/or incur term loans) in an aggregate amount not to exceed $250.0 million.
    The revolving credit facility will mature on May 29, 2030, which was extended from the prior maturity date of April 29, 2027.
    Principal amounts outstanding under the revolving credit facility accrue interest, at the option of the borrowers, either (a) at an
    alternate base rate plus an applicable margin not to exceed 0.50% per annum, or (b) at SOFR (or a similar benchmark for non-
    US dollar borrowings) plus a 0.10% adjustment and an applicable margin not to exceed 1.50% per annum. The Company also is
    required to pay a quarterly commitment fee on the unused commitments under its revolving credit facility not to exceed 0.15%
    per annum, as well as certain customary fees for any issued letters of credit.
    The revolving credit facility is unsecured. The Company is required to maintain management fee earning assets (as defined in
    the Third Amended and Restated Credit Agreement) of at least $156.9 billion and a total leverage ratio of less than 4.0 to 1.0, in
    each case, tested on a quarterly basis. Non-compliance with any of the financial or non-financial covenants without cure or
    waiver would constitute an event of default under the Third Amended and Restated Credit Agreement. An event of default
    resulting from a breach of certain financial or non-financial covenants may result, at the option of the lenders, in an acceleration
    of the principal and interest outstanding, and a termination of the Third Amended and Restated Credit Agreement. The Third
    Amended and Restated Credit Agreement also contains other customary events of default, including defaults based on events of
    bankruptcy and insolvency, nonpayment of principal, interest, or fees when due, breach of specified covenants, change in
    control, and material inaccuracy of representations and warranties.
    Under the Third Amended and Restated Credit Agreement, Citibank N.A. and certain of its affiliates act as Joint Lead Arranger
    and Bookrunner, Administrative Agent, and Lender; J.P. Morgan Chase Bank, N.A and certain of its affiliates act as Joint Lead
    Arranger and Bookrunner, Syndication Agent, and Lender; BofA Securities, Inc. and certain of its affiliates act as Joint Lead
    Arranger and Bookrunner; Wells Fargo Securities, LLC and certain of its affiliates act as Joint Lead Arranger and Bookrunner;
    Bank of America, N.A. and certain of its affiliates act as Syndication Agent and Lender; Wells Fargo Bank, National
    Association and certain of its affiliates act as Syndication Agent and Lender; and affiliates of Barclays Bank PLC, Deutsche
    Bank AG, Goldman Sachs Bank USA, HSBC Bank USA, N.A., Morgan Stanley Bank, N.A., Societe Generale, and UBS AG
    act as Lenders.
    Certain of the lenders and/or their respective affiliates have, from time to time, performed, and may in the future perform,
    various investment banking, financial advisory, lending, and other services in the ordinary course of business for the Company
    and/or its affiliates, the investment funds the Company manages, and the Company’s investment funds’ portfolio companies,
    for which they have received or will receive customary fees and expenses, and in some cases, customary indemnification.
    Item 5.07
    Submission of Matters to a Vote of Security Holders.
    On May 29, 2025, the Company held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”). The Company’s
    shareholders considered three proposals, each of which is described in more detail in the Company’s Definitive Proxy
    Statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission on April 17, 2025. The final voting
    results for each matter submitted to a vote of shareholders at the Annual Meeting were as follows:
    Item 1.  Election to Our Board of Directors of Eight Director Nominees for a One-Year Term
    FOR
    WITHHELD
    BROKER NON-VOTES
    David M. Rubenstein
    286,265,369
    7,705,054
    41,214,348
    Daniel A. D’Aniello
    286,627,452
    7,342,971
    41,214,348
    Harvey M. Schwartz
    290,431,822
    3,538,601
    41,214,348
    Sharda Cherwoo
    290,446,365
    3,524,058
    41,214,348
    Linda H. Filler
    278,562,713
    15,407,710
    41,214,348
    James H. Hance, Jr.
    275,455,934
    18,514,489
    41,214,348
    Derica W. Rice
    280,018,902
    13,951,521
    41,214,348
    William J. Shaw
    278,222,745
    15,747,678
    41,214,348
    Item 2.  Ratification of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2025
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    325,250,893
    9,836,306
    97,372
    —
    Item 3.  Non-Binding Vote to Approve Named Executive Officer Compensation (“Say-on-Pay”)
    FOR
    AGAINST
    ABSTAIN
    BROKER NON-VOTES
    206,466,540
    87,041,794
    461,889
    41,214,348
    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
    its behalf by the undersigned hereunto duly authorized.
     
     
    The Carlyle Group Inc.
    Date: May 30, 2025
     
     
    By:
     
    /s/ Jeffrey W. Ferguson
     
     
    Name:
     
    Jeffrey W. Ferguson
     
     
    Title:
     
    General Counsel
    Get the next $CG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    8/27/2024$55.00Buy
    Redburn Atlantic
    8/6/2024$46.00 → $44.00Overweight → Neutral
    JP Morgan
    1/19/2024$40.00 → $41.00Buy → Neutral
    Citigroup
    1/4/2024$42.00Market Perform
    TD Cowen
    More analyst ratings

    $CG
    SEC Filings

    See more
    • The Carlyle Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Submission of Matters to a Vote of Security Holders

      8-K - Carlyle Group Inc. (0001527166) (Filer)

      5/30/25 5:19:46 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

      SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

      5/13/25 11:44:13 AM ET
      $CG
      Investment Managers
      Finance
    • SEC Form 13F-HR filed by The Carlyle Group Inc.

      13F-HR - Carlyle Group Inc. (0001527166) (Filer)

      5/9/25 4:37:58 PM ET
      $CG
      Investment Managers
      Finance

    $CG
    Financials

    Live finance-specific insights

    See more
    • Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended March 31, 2025, Declares Second Quarter 2025 Dividend of $0.40 Per Common Share

      NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its first quarter ended March 31, 2025. Justin Plouffe, CGBD's Chief Executive Officer, said, "Following successful completion of the merger with CSL III at the end of March, CGBD remains focused on driving stable income, consistent credit performance, and disciplined execution of our strategy. Complementing our conservative investing approach, we continue to optimize the capital structure of CGBD, increasing total commitments on our credit facility and exchanging the pre

      5/6/25 4:05:00 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services
    • Carlyle Credit Income Fund Schedules Second Quarter Financial Results and Investor Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, May 20, 2025, for its second quarter of 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, May 21, 2025, to discuss the results. The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion. About Carlyle Credit Income Fund Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end f

      4/16/25 4:46:22 PM ET
      $CCIF
      $CG
      Finance/Investors Services
      Finance
      Investment Managers
    • Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the First Quarter Ended March 31, 2025

      NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, May 7, 2025 to announce its financial results for the first quarter ended March 31, 2025. The Company will report its quarterly financial results on Tuesday, May 6, 2025. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc. Carlyle Secured Lending, Inc. is a publicly traded (NASDAQ:CGBD) business development company (

      4/15/25 4:25:17 PM ET
      $CG
      $CGBD
      Investment Managers
      Finance
      Finance: Consumer Services

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • General Counsel Ferguson Jeffrey W. was granted 1,368 shares, increasing direct ownership by 0.12% to 1,097,293 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:59 PM ET
      $CG
      Investment Managers
      Finance
    • Chief Executive Officer Schwartz Harvey M was granted 31,709 shares, increasing direct ownership by 0.51% to 6,188,889 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:50 PM ET
      $CG
      Investment Managers
      Finance
    • Chief Accounting Officer Andrews Charles Elliott Jr. was granted 302 shares, increasing direct ownership by 0.21% to 144,121 units (SEC Form 4)

      4 - Carlyle Group Inc. (0001527166) (Issuer)

      5/29/25 5:09:40 PM ET
      $CG
      Investment Managers
      Finance
    • Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

      All conditions of the Offer have been satisfied and the parties expect to consummate the acquisition on June 2, 2025 Carlyle (NASDAQ:CG) ("Carlyle"), SK Capital Partners, LP ("SK Capital") and Beacon Parent Holdings, L.P. ("Parent") today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of bluebird bio, Inc. (NASDAQ:BLUE) ("bluebird") for either (x) $3.00 per share in cash and a contingent value right per share, entitling the holder to a payment of $6.84 in cash per contingent value right ("CVR") if bluebird's current product portfolio achieves $600 million in net sales in any trailing 12-month period prior to or ending on December

      5/30/25 8:30:00 AM ET
      $BLUE
      $CG
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Investment Managers
      Finance
    • Resonetics® Invests in Nitinol Gun Drilling Capabilities Through Purchase of Assets from Medical Component Specialists

      Establishes nitinol input tube operation to support premium, implant-grade tubing initiative and strengthen supply chain resilience NASHUA, N.H., May 19, 2025 /PRNewswire/ -- Resonetics® announced today that it has acquired the nitinol gun drilling operations and related assets of Medical Component Specialists' (MCS) New Boston, NH facility.  This acquisition marks another key investment in Resonetics' comprehensive U.S.-based nitinol strategy. This transaction follows the meaningful steps that Resonetics has taken to expand the availability of material and supply of nitinol, a crucial material for the most innovative next generation medical devices.

      5/19/25 10:00:00 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions

      Stockholders that have previously tendered their shares must re-tender their shares Stockholders may elect to receive either $3.00 per share plus CVR of $6.84 per share in cash payable upon achievement of a net sales milestone or $5.00 per share with no CVR As previously announced on May 14, 2025, Carlyle (NASDAQ:CG) ("Carlyle"), SK Capital Partners, LP ("SK Capital") and bluebird bio, Inc. (NASDAQ:BLUE) ("bluebird"), have amended their definitive agreement pursuant to which Carlyle and SK Capital will purchase all of the outstanding shares of bluebird. The parties have issued the following updated instructions for stockholders to tender their shares into the offer. Updated Instructions

      5/16/25 4:30:00 PM ET
      $BLUE
      $CG
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Investment Managers
      Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    See more
    • SoftBank Group to Acquire Ampere Computing

      SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

      3/19/25 7:30:00 PM ET
      $CG
      $ORCL
      Investment Managers
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

      MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost. "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Boar

      2/4/25 9:58:04 AM ET
      $CG
      Investment Managers
      Finance
    • Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer

      MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced it has appointed Ezmeralda Sager as Executive Vice President and Chief Transformation Officer (CTO), effective January 6, 2025. In this role, Sager will spearhead enterprise-wide change initiatives to help Acentra Health build upon its strong track record of innovation and execution for its clients. She will provide strategic guidance on process improvements to optimize the development and delivery of the company's products, solutions

      1/23/25 9:42:00 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Carlyle Group upgraded by TD Cowen with a new price target

      TD Cowen upgraded Carlyle Group from Hold to Buy and set a new price target of $56.00

      5/14/25 8:48:54 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group downgraded by Oppenheimer

      Oppenheimer downgraded Carlyle Group from Outperform to Perform

      3/19/25 8:14:15 AM ET
      $CG
      Investment Managers
      Finance
    • Carlyle Group upgraded by Wolfe Research with a new price target

      Wolfe Research upgraded Carlyle Group from Peer Perform to Outperform and set a new price target of $60.00

      1/3/25 7:19:04 AM ET
      $CG
      Investment Managers
      Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

      11/15/24 5:22:29 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/21/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

      SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

      10/15/24 4:31:27 PM ET
      $CG
      Investment Managers
      Finance